Calcific Uremic Arteriolopathy: Clinical Trials

2 trials for Calcific Uremic Arteriolopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Withdrawn 1

Follow Calcific Uremic Arteriolopathy: new trials by email Literature Review of Calcific Uremic Arteriolopathy trials Research Report on Calcific Uremic Arteriolopathy

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of SNF472 for Calciphylaxis
Experimental: SNF472, Placebo Comparator: Placebo, Experimatenl SNF472 (Open-label) - Calciphylaxis, Calcific Uremic Arteriolopathy
Phase 3CompletedSanifit Therapeutics S. A.712020-02-122024-02-20
Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy
Sodium thiosulfate, Placebo - Calciphylaxis, Calcific Uremic Arteriolopathy
Phase 3WithdrawnAmerican Regent, Inc.2015-01-302025-05-07

Narrower conditions

Calciphylaxis (2)  ·  Kidney Failure, Chronic (1)  ·  Wounds and Injuries (1)

Broader conditions

Calcinosis (2)  ·  Calcium Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Renal Insufficiency, Chronic (1)  ·  Urogenital Diseases (1)

Interventions

Sodium Chloride (1)  ·  sodium thiosulfate (1)

Sponsors

American Regent, Inc. (1)  ·  Sanifit Therapeutics S. A. (1)

Countries

United States (2)  ·  Belgium (1)  ·  Germany (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Alex Gold, MD (1)  ·  Linda Mundy, MD, PhD (1)

Results publications

PMID 39186385, PMID 39252867